Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ALK | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
mRNA | DMRT1 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-09 |
mRNA | ZKSCAN1 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-09 |
mRNA | FRS3 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
mRNA | FAM89A | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
mRNA | CLEC4F | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
mRNA | TRERF1 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
mRNA | BATF3 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
mRNA | IL1RAP | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
mRNA | DMBX1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |